Healthcare Logistics Market Size, Share & Trends Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Healthcare Logistics Market Size Analysis

Global Healthcare Logistics Market Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value

North America Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value
U.S.
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation Services
    1. By Value
  3. Freight Forwarding Services
    1. By Value
  4. Warehousing and Distribution
    1. By Value
  5. Value-added Services
    1. By Value
  6. Others
    1. By Value
2. By Industry
  1. Introduction
    1. Industry By Value
  2. Pharmaceutical
    1. By Value
  3. Biopharmaceutical
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Plasma-Derived Products
      1. Plasma-Derived Products By Value
    4. Others
      1. Others By Value
  4. Medical Devices
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnological Companies
    1. By Value
  3. Medical Device Companies
    1. By Value
  4. Healthcare Facilities
    1. By Value
  5. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value
U.K.
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation Services
    1. By Value
  3. Freight Forwarding Services
    1. By Value
  4. Warehousing and Distribution
    1. By Value
  5. Value-added Services
    1. By Value
  6. Others
    1. By Value
2. By Industry
  1. Introduction
    1. Industry By Value
  2. Pharmaceutical
    1. By Value
  3. Biopharmaceutical
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Plasma-Derived Products
      1. Plasma-Derived Products By Value
    4. Others
      1. Others By Value
  4. Medical Devices
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnological Companies
    1. By Value
  3. Medical Device Companies
    1. By Value
  4. Healthcare Facilities
    1. By Value
  5. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value
China
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation Services
    1. By Value
  3. Freight Forwarding Services
    1. By Value
  4. Warehousing and Distribution
    1. By Value
  5. Value-added Services
    1. By Value
  6. Others
    1. By Value
2. By Industry
  1. Introduction
    1. Industry By Value
  2. Pharmaceutical
    1. By Value
  3. Biopharmaceutical
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Plasma-Derived Products
      1. Plasma-Derived Products By Value
    4. Others
      1. Others By Value
  4. Medical Devices
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnological Companies
    1. By Value
  3. Medical Device Companies
    1. By Value
  4. Healthcare Facilities
    1. By Value
  5. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value
UAE
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation Services
    1. By Value
  3. Freight Forwarding Services
    1. By Value
  4. Warehousing and Distribution
    1. By Value
  5. Value-added Services
    1. By Value
  6. Others
    1. By Value
2. By Industry
  1. Introduction
    1. Industry By Value
  2. Pharmaceutical
    1. By Value
  3. Biopharmaceutical
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Plasma-Derived Products
      1. Plasma-Derived Products By Value
    4. Others
      1. Others By Value
  4. Medical Devices
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnological Companies
    1. By Value
  3. Medical Device Companies
    1. By Value
  4. Healthcare Facilities
    1. By Value
  5. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Service
1. Introduction
  1. Service By Value
2. Transportation Services
  1. By Value
3. Freight Forwarding Services
  1. By Value
4. Warehousing and Distribution
  1. By Value
5. Value-added Services
  1. By Value
6. Others
  1. By Value
By Industry
1. Introduction
  1. Industry By Value
2. Pharmaceutical
  1. By Value
3. Biopharmaceutical
  1. By Value
  2. Vaccines
    1. Vaccines By Value
  3. Plasma-Derived Products
    1. Plasma-Derived Products By Value
  4. Others
    1. Others By Value
4. Medical Devices
  1. By Value
  2. Class I
    1. Class I By Value
  3. Class II
    1. Class II By Value
  4. Class III
    1. Class III By Value
By Supply Chain
1. Introduction
  1. Supply Chain By Value
2. Cold Chain
  1. By Value
3. Non-Cold Chain
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Pharmaceutical & Biotechnological Companies
  1. By Value
3. Medical Device Companies
  1. By Value
4. Healthcare Facilities
  1. By Value
5. Others
  1. By Value
Brazil
1. By Service
  1. Introduction
    1. Service By Value
  2. Transportation Services
    1. By Value
  3. Freight Forwarding Services
    1. By Value
  4. Warehousing and Distribution
    1. By Value
  5. Value-added Services
    1. By Value
  6. Others
    1. By Value
2. By Industry
  1. Introduction
    1. Industry By Value
  2. Pharmaceutical
    1. By Value
  3. Biopharmaceutical
    1. By Value
    2. Vaccines
      1. Vaccines By Value
    3. Plasma-Derived Products
      1. Plasma-Derived Products By Value
    4. Others
      1. Others By Value
  4. Medical Devices
    1. By Value
    2. Class I
      1. Class I By Value
    3. Class II
      1. Class II By Value
    4. Class III
      1. Class III By Value
3. By Supply Chain
  1. Introduction
    1. Supply Chain By Value
  2. Cold Chain
    1. By Value
  3. Non-Cold Chain
    1. By Value
4. By End User
  1. Introduction
    1. End User By Value
  2. Pharmaceutical & Biotechnological Companies
    1. By Value
  3. Medical Device Companies
    1. By Value
  4. Healthcare Facilities
    1. By Value
  5. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Healthcare Logistics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Alloga Ltd.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
AmerisourceBergen Corporation
AWL INDIA
BOLLORE
CEVA Logistics
DHL Group
DSV
Expeditors International of Washington, Inc.
Farmasoft
FedEx
FM Logistics
GEODIS
NextPharma Logistics GmbH
NIPPON EXPRESS HOLDINGS
noatum logistics
SCHENKER
United Parcel Service of America, Inc.
Yusen Logistics Global Management Co., Ltd
Cencora

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment